Sarepta Therapeutics Inc (FRA:AB3A)
€ 17.52 +0.74 (+4.32%) Market Cap: 1.85 Bil Enterprise Value: 2.08 Bil PE Ratio: 0 PB Ratio: 1.42 GF Score: 61/100

Sarepta Therapeutics Inc (FRA:AB3A) Transcripts

  • 1